Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014258 |
| CAS No | NA |
| Mol.F. | C18H17N3O |
| Mol.Wt. | 291.4g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014259 |
| CAS No | NA |
| Mol.F. | C32H29F5N4O6 |
| Mol.Wt. | 660.59 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014260 |
| CAS No | NA |
| Mol.F. | C18H23N3O6 |
| Mol.Wt. | 377.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014261 |
| CAS No | 2901109-58-6 |
| Mol.F. | C17H19F6N3O4 |
| Mol.Wt. | 443.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014262 |
| CAS No | NA |
| Mol.F. | C19H23N3O5 |
| Mol.Wt. | 373.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014263 |
| CAS No | NA |
| Mol.F. | C7H9N3O5S |
| Mol.Wt. | 247.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014264 |
| CAS No | NA |
| Mol.F. | C22H29N7O2S |
| Mol.Wt. | 455.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N014265 |
| CAS No | NA |
| Mol.F. | C24H27N3O4 |
| Mol.Wt. | 421.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N014266 |
| CAS No | NA |
| Mol.F. | C12H18N2O4 |
| Mol.Wt. | 254.3 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014267 |
| CAS No | NA |
| Mol.F. | C29H25ClFN5O5S |
| Mol.Wt. | 610.06 |
| INV STATUS | In Stock |
| CAT No | SRC-N014268 |
| CAS No | NA |
| Mol.F. | C25H29F3N4O5 |
| Mol.Wt. | 522.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014269 |
| CAS No | 3032026-54-0 |
| Mol.F. | C16H19N3O2 |
| Mol.Wt. | 285.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014270 |
| CAS No | NA |
| Mol.F. | C32H28F5N4O6 |
| Mol.Wt. | 659.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014271 |
| CAS No | NA |
| Mol.F. | C52H42F10N6O9 |
| Mol.Wt. | 1084.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014272 |
| CAS No | NA |
| Mol.F. | C13H16ClN3O4 |
| Mol.Wt. | 313.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N014273 |
| CAS No | NA |
| Mol.F. | C21H20N4O6 |
| Mol.Wt. | 424.4 g/mol |
| INV STATUS | In Stock |